ZAI Laboratory ADR Representing
Stock
Stock
ISIN: US98887Q1040
Ticker: ZLAB
US98887Q1040
ZLAB
Price
Price
CHART BY
Frequently asked questions
What is ZAI Laboratory ADR Representing's market capitalization?
The market capitalization of ZAI Laboratory ADR Representing is $2.91B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for ZAI Laboratory ADR Representing?
ZAI Laboratory ADR Representing's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$2.781. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for ZAI Laboratory ADR Representing's stock?
Currently, 11 analysts cover ZAI Laboratory ADR Representing's stock, with a consensus target price of $50.19. Analyst ratings provide insights into the stock's expected performance.
What is ZAI Laboratory ADR Representing's revenue over the trailing twelve months?
Over the trailing twelve months, ZAI Laboratory ADR Representing reported a revenue of $355.75M.
What is the EBITDA for ZAI Laboratory ADR Representing?
ZAI Laboratory ADR Representing's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$318.74M. EBITDA measures the company's overall financial performance.
What is the free cash flow of ZAI Laboratory ADR Representing?
ZAI Laboratory ADR Representing has a free cash flow of -$178.00M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does ZAI Laboratory ADR Representing have, and what sector and industry does it belong to?
ZAI Laboratory ADR Representing employs approximately 2,175 people. It operates in the Health Care sector, specifically within the Biotechnology industry.
What is the free float of ZAI Laboratory ADR Representing's shares?
The free float of ZAI Laboratory ADR Representing is 108.70M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $2.91B
- EPS (TTM)
- -$2.781
- Free Float
- 108.70M
- Revenue (TTM)
- $355.75M
- EBITDA (TTM)
- -$318.74M
- Free Cashflow (TTM)
- -$178.00M
Pricing
- 1D span
- $26.30$27.03
- 52W span
- $13.50$36.50
Analyst Ratings
The price target is $50.19 and the stock is covered by 11 analysts.
Buy
9
Hold
2
Sell
0
Information
Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.
- Employees
- 2,175
- Industries
- Biotechnology
- Sector
- Health Care
Identifier
- ISIN
- US98887Q1040
- Primary Ticker
- ZLAB